Veklury 100 mg powder for concentrate for solution for infusion

DRUG3 trials

Sponsors

Inserm, Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La C, Region Vaesterbotten, Umea University

Conditions

COVID-10 infectionCOVID-19 and Severely Impaired B-cell FunctionCovid-19

Phase 2

OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Study

RecruitingCTIS2022-501408-81-01

Start: 2024-03-04Target: 304Updated: 2025-12-19

SAFETY AND EFFICACY OF A 10-DAY COURSE OF REMDESIVIR TO PREVENT SEVERE COVID-19 IN ASYMPTOMATIC OR PAUCISYMPTOMATIC SARS-COV-2-POSITIVE KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-ARM PROOF-OF-CONCEPT INTERVENTIONAL TRIAL

RecruitingCTIS2024-519272-96-00

Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La CCOVID-10 infection

Start: 2025-08-07Target: 15Updated: 2025-06-30

Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone for Coronavirus Disease 2019 (COVID-19) in Patients with Severely Impaired B-cell Function

Not yet recruitingCTIS2025-522756-97-00

Region Vaesterbotten, Umea UniversityCOVID-19 and Severely Impaired B-cell Function

Target: 92Updated: 2026-02-06